Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers. - Madan A; Markison S; Betz SF; Krasner A; Luo R; Jochelson T; Lickliter J; Struthers RS (Pituitary, 2022)